Search

Introduction. The main challenge in cancer care during the Covid-19 pandemic was to ensure the timeliness of diagnosis and treatment of nearly 100,000 new cancer cases per year in Colombia. The objective of this research was to know the response of the Health Service Provider Institutions on their management of services for cancer care in the first semester of the year 2020. Methodology. Descriptive, cross-sectional, survey-type study on the characterization of cancer patients with Covid-19, installed capacity, comprehensive cancer care, telehealth/telemedicine implementation, and institutional support during the pandemic. Twenty-five providers with oncological surgery and chemotherapy or radiotherapy services participated. Results. Fifty-six percent of providers reported cancer patients with Covid-19. Everyone reported management changes in pandemic response capacity: 76% upgraded infrastructure and devices, 84% adopted telehealth/telemedicine and 92% received assistance in action plans. Forty-eight percent of the provider institutions showed a decrease in cancer screening. Discussion. This study shows that the emergency of the pandemic forced to rush the efforts of infrastructure and resources in the oncological entities of Colombia. The results obtained in the decrease of cancer screening nationally will be equated with the data reported by different countries, including the Americas region. Conclusion. The findings show the need to improve the response capacity of the health care system in health emergency scenarios to avoid delays in cancer care and public health actions. [ABSTRACT FROM AUTHOR]

Copyright of Revista de Salud Pública is the property of Universidad Nacional de Colombia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)